e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical and functional evaluation of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts)
Y. Huba (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), D. Koval (Dnipro, Ukraine)
Source:
Virtual Congress 2020 – Clinical and functional evaluation of COPD
Session:
Clinical and functional evaluation of COPD
Session type:
E-poster session
Number:
537
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Huba (Dnipro, Ukraine), L. Konopkina (Dnipro, Ukraine), T. Pertseva (Dnipro, Ukraine), D. Koval (Dnipro, Ukraine). Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts). 537
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
The types and frequency of mental disorders in COPD patients (pts) according to severity of COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Determination of the optimal questionnaire to identify mental disorders COPD in patients (pts)
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Mental disorders in patients (pts) with COVID-19 pneumonia:comparison with COPD exacerbation
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Worsening of functional limitations and health status in patients with chronic obstructive pulmonary (COPD) as compared to patients with other chronic illnesses in a national sample of US adults
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR)
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013
Impact of co-morbidities on the rehabilitation outcome in COPD patients
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
Effects of the type of in-home caregiver on outcome in elderly chronic obstructive pulmonary disease (COPD) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 169s
Year: 2003
The aimful treatment of hemorheological disorders (HD) in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 425s
Year: 2003
Prediction of vascular-platelet hemostasis disorders in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020
The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Assessment of pulmonary rehabilitation (PR) safety in patients with chronic respiratory diseases
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001
Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Does the chronic respiratory disease questionnaire (CRDQ) relate to hospital admission rates in chronic obstructive pulmonary disease (COPD) patients
Source: Eur Respir J 2002; 20: Suppl. 38, 249s
Year: 2002
Validation of two physical activity questionnaires in a population of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 632s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept